Metformin, a commonly used drug for the treatment of diabetes, can reduce the biosynthesis of cholesterol by blocking the BCR signaling pathway and inhibiting the expression of HMGCS1, thereby inhibiting the growth of DLBCL. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.